The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint
microRNAs (miRs) are emerging as attractive therapeutic targets because of their small size, specific targetability, and critical role in disease pathogenesis. However, <20 miR targeting molecules have entered clinical trials, and none progressed to phase III. The difficulties in miR target ident...
Guardado en:
Autores principales: | Mohammad Yahya Momin, Ravinder Reddy Gaddam, Madeline Kravitz, Anisha Gupta, Ajit Vikram |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d2384e466034a058851f9185a462798 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis Monocytes
por: Paul J. McKiernan, et al.
Publicado: (2021) -
Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
por: Bakr Zaki M, et al.
Publicado: (2019) -
Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome
por: Karin Sanders, et al.
Publicado: (2021) -
The evolutionary dynamics of microRNAs in domestic mammals
por: Luca Penso-Dolfin, et al.
Publicado: (2018) -
Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma
por: Esther K. Elliott, et al.
Publicado: (2021)